Matrix Pharma Corp
Anil Kumar Jain is a seasoned professional in the pharmaceutical and chemical engineering sectors, currently serving as the Chief Executive Officer of Matrix Pharma Corp since August 2024. Previously, Anil held the position of Managing Director at PI Health Sciences from July 2022 to July 2024, showcasing expertise in building and managing large-scale CDMO and Generic Business Platforms for advanced regulatory markets. Anil's extensive experience includes serving as the CEO of Global API Business at Sun Pharmaceuticals, overseeing operations worth USD 550 million with a global workforce of 4,000, and leading the Global API Business as Chief Operating Officer at AUROBINDO PHARMA LTD. Anil began a career in pharmaceuticals at Lupin Ltd, progressing from Graduate Engineering Trainee to Works Manager, and has a strong academic foundation with an M. Tech in Chemical Engineering from Jawaharlal Nehru Technological University and an Executive Leadership Development Program from the Indian Institute of Management Bangalore.
This person is not in any teams
Matrix Pharma Corp
Matrix Pharma Corp is India's leading integrated API manufacturer, dedicated to delivering high-quality, innovative solutions for the world's leading pharma companies in over 80 counties. We operate 6 state-of-the-art USFDA, EU GMP, and WHO certified manufacturing facilities across India, with expertise that spans a wide range of APIs, including complex molecules and high-potency ingredients. Matrix offers comprehensive CDMO services to support pharmaceutical companies with custom synthesis, process development, and manufacturing, backed by a robust R&D team of 1,500 scientists. Over the past 2 decades we have built strong partnerships with leading pharmaceutical companies by delivering products of global quality standard, reliably, with a shared commitment to improving healthcare access and affordability for all. Tianish Laboratories Pvt. Ltd. is a 100% subsidiary of Matrix Pharma.